List of investigational sleep drugs
This is a list of investigational sleep drugs, or drugs for the treatment of sleep disorders that are currently under development for clinical use but are not yet approved. Chemical/generic names are listed first, with developmental code names, synonyms, and brand names in parentheses.
Insomnia
GABAA receptor potentiators
- EVT-201 – GABAA receptor positive allosteric modulator
- Lorediplon (GF-015535-00) – GABAA receptor positive allosteric modulator
- Remimazolam (HR-7056) – GABAA receptor positive allosteric modulator
- Zuranolone (SAGE-217) – GABAA receptor positive allosteric modulator
Orexin receptor antagonists
- Daridorexant (nemorexant; ACT-541468) – orexin receptor antagonist
- Seltorexant (MIN-202, JNJ,42847922, JNJ-922) – selective OX2 receptor antagonist
Melatonin receptor agonists
- Piromelatine (Neu-P11) – melatonin receptor agonist and 5-HT1A and 5-HT1D receptor agonist
Others/undefined
- IMB-115 (V-117957) – novel mechanism of action (ORL-1 agonist)
Hypersomnia/narcolepsy
Orexin receptor agonists
- TAK-925 – OX2 receptor-selective agonist via IV infusion [1]
- TAK-994 – OX2 receptor agonist pill (orally available) [1]
Monoaminergics
- Flecainide/modafinil (THN-102) – modafinil (dopamine reuptake inhibitor) and flecainide (antiarrhythmic) combination
- JZP-507 – dopamine receptor agonist
- Mazindol controlled release (NLS-1001, NLS-1) – norepinephrine-predominant serotonin–norepinephrine–dopamine reuptake inhibitor (SNDRI)
- Phacetoperane (NLS-3) – norepinephrine–dopamine reuptake inhibitor (NDRI)
- (r)-phenylpiracetam - dopamine reuptake inhibitor
- AXS-12 (Reboxetine) - norepinephrine reuptake inhibitor (NRI) for cataplexy
GHB receptor agonists
- FT-218 (sodium oxybate controlled release) – GHB and GABAB receptor agonist
- JZP-258 (oxybate mixed salt solution) – GHB and GABAB receptor agonist
- JZP-386 (C-10323; deuterated sodium oxybate) – GHB and GABAB receptor agonist
- JZP-507 (oxybate mixed salt solution) – GHB and GABAB receptor agonist
H3 receptor inverse agonists
- LGD-3437 – H3 receptor antagonist
GABAA receptor inhibitors
- Golexanolone – GABAA receptor negative allosteric modulator
- Pentylenetetrazole (BTD-001) – GABAA receptor negative allosteric modulator
- GR3027 - an antagonist at GABAA receptors (GABAARs)
See also
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.